Rueil-Malmaison, France

Alain Gobert


Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 29(Granted Patents)


Location History:

  • Saint Denis, FR (1997 - 1999)
  • Rueil-Malmaison, FR (2000 - 2008)

Company Filing History:


Years Active: 1997-2008

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Alain Gobert

Introduction

Alain Gobert, a prominent inventor based in Rueil-Malmaison, France, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 10 patents, Gobert's work focuses on developing novel compounds with therapeutic applications. His innovative approach has led to advancements that are essential in the treatment of various medical conditions.

Latest Patents

Gobert's latest patents include groundbreaking compounds that show promise in medical applications. One of his notable inventions is a class of indanyl-piperazine compounds, which are designed for use in medical products targeting conditions that require serotonin reuptake inhibitors and/or NK antagonists. In addition, he has developed indoline compounds that possess therapeutic potential, featuring a unique structure that includes a benzo ring optionally substituted by a range of functional groups. These compounds, along with their enantiomers, diastereoisomers, and addition salts, are crucial in the formulation of new medicaments for healthcare.

Career Highlights

Throughout his career, Alain Gobert has worked with esteemed organizations such as Adir Et Compagnie and Les Laboratoires Servier. His tenure at these companies allowed him to apply his expertise in medicinal chemistry, driving forward projects that have resulted in innovative products ready for the market. His direct involvement in research and development has established him as a key figure in pharmaceutical innovation.

Collaborations

Alain Gobert has collaborated with notable individuals in the field, including Mark Millan and Jean-Louis Peglion. These partnerships have enabled Gobert to combine ideas and knowledge, further enhancing the quality and impact of his inventions. Together, they have engaged in research that emphasizes the importance of collaboration in the advancement of pharmaceutical sciences.

Conclusion

In summary, Alain Gobert is a distinguished inventor whose patents have contributed significantly to medicinal chemistry. His latest innovations in indanyl-piperazine and indoline compounds demonstrate his commitment to improving medical treatments. As he continues to work alongside talented colleagues and reputable companies, Gobert's legacy in the world of invention and innovation is sure to inspire future generations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…